InsidersTradesSigma
Track the Hangzhou Diagens Biotechnology Co., Ltd. - B share price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, Hangzhou Diagens Biotechnology Co., Ltd. - B has published 1 public disclosures. Market capitalisation: €27.5bn. The latest transaction was disclosed on 14 April 2026 (Other). Among the most active insiders: SONG Ning. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Hangzhou Diagens Biotechnology Co., Ltd. is a company focused on developing biopharmaceutical solutions. It is listed on the Hong Kong Stock Exchange.